Oncology PracticeSubcutaneous Antifibrinolytic Reduces Bleeding After Mohs SurgeryMay 22, 2024Nonmelanoma Skin CancerMelanoma
Oncology PracticeUrine Tests Could Be ‘Enormous Step’ in Diagnosing CancerMay 22, 2024Preventive CarePractice ManagementPatient & Survivor CareCNS/Brain CancerBreast CancerDLBCLFollicular Lymphoma
Oncology PracticeStatin Use May Extend Life for Early Breast Cancer PatientsMay 21, 2024Breast CancerPatient & Survivor Care
Oncology PracticeFormer UCLA Doctor Receives $14 Million in Gender Discrimination RetrialMay 21, 2024Business of MedicinePractice ManagementDiversity in Medicine
Hematology NewsHow Physician Mortgage Loans Work for Doctors With DebtMay 20, 2024Business of MedicinePractice Management
Oncology Practice‘Big Breakthrough’: New Low-Field MRI Is Safer and EasierMay 20, 2024Preventive CareLung Cancer
Hematology NewsCrossing State Lines: PA Licensure Compact Coming SoonMay 20, 2024Business of MedicinePractice Management
Hematology NewsFollow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate MarkersMay 20, 2024Business of MedicineMixed Topics
Oncology PracticeNew Immunotherapy Combo Shows Promise for Triple-Negative Breast CancerMay 20, 2024Metastatic Breast CancerBreast CancerPatient & Survivor Care
Oncology PracticeART Safe for Breast Cancer Survivors with BRCA1/2 MutationsMay 17, 2024Breast CancerPatient & Survivor Care
Oncology PracticeFDA Approves Tarlatamab for Extensive-Stage Small Cell Lung CancerMay 17, 2024Lung CancerMixed TopicsPractice Management
Oncology PracticeNo Improvement in OS With Atezolizumab in Early Relapsing TNBCMay 17, 2024Breast CancerPatient & Survivor Care
Oncology PracticeChatbots Seem More Empathetic Than Docs in Cancer DiscussionsMay 16, 2024Patient & Survivor CarePractice ManagementPreventive CareRenal Cell CarcinomaSarcoma & GISTBreast CancerCNS/Brain Cancer
Hematology NewsFDA Broadens Breyanzi’s Follicular Lymphoma IndicationMay 16, 2024Non-Hodgkin LymphomaCellular TherapyIndolent Lymphoma
Oncology PracticeTucatinib-Trastuzumab Benefit ‘Remarkable’ in HER2-positive mCRCMay 16, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor CareBreast Cancer
